Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries | Ca-A Cancer Journal for Clinicians | 2018 | 41.6K |
Global cancer statistics | Ca-A Cancer Journal for Clinicians | 2011 | 26.4K |
Global cancer statistics, 2012 | Ca-A Cancer Journal for Clinicians | 2015 | 20.7K |
Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012 | International Journal of Cancer | 2015 | 19.3K |
Global cancer statistics, 2002 | Ca-A Cancer Journal for Clinicians | 2005 | 14.4K |
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial | JAMA - Journal of the American Medical Association | 2002 | 12.1K |
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 | International Journal of Cancer | 2010 | 12.1K |
Cancer Statistics, 2017 | Ca-A Cancer Journal for Clinicians | 2017 | 12K |
Cancer statistics, 2018 | Ca-A Cancer Journal for Clinicians | 2018 | 12K |
Cancer statistics, 2010 | Ca-A Cancer Journal for Clinicians | 2010 | 11K |
A genetic model for colorectal tumorigenesis | Cell | 1990 | 9.4K |
Cancer statistics, 2012 | Ca-A Cancer Journal for Clinicians | 2012 | 9.4K |
Cancer statistics, 2008 | Ca-A Cancer Journal for Clinicians | 2008 | 8.9K |
Safety, activity, and immune correlates of anti-PD-1 antibody in cancer | New England Journal of Medicine | 2012 | 8.7K |
Cancer statistics, 2009 | Ca-A Cancer Journal for Clinicians | 2009 | 8.6K |
Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer | New England Journal of Medicine | 2004 | 8.5K |
Mutations of the BRAF gene in human cancer | Nature | 2002 | 8K |
Immunity, inflammation, and cancer | Cell | 2010 | 6.8K |
Cancer statistics, 2007 | Ca-A Cancer Journal for Clinicians | 2007 | 6.4K |
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults | New England Journal of Medicine | 2003 | 5.7K |
Comprehensive molecular characterization of human colon and rectal cancer | Nature | 2012 | 5.6K |
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency | New England Journal of Medicine | 2015 | 5.6K |
Safety and activity of anti-PD-L1 antibody in patients with advanced cancer | New England Journal of Medicine | 2012 | 5.5K |
Genetic alterations during colorectal-tumor development | New England Journal of Medicine | 1988 | 5.4K |
Gene Selection for Cancer Classification using Support Vector Machines | Machine Learning | 2002 | 5.2K |